Biotech stocks are high-risk ... the stock prices of the respective companies in an appreciable manner. 1. Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Date: Tuesday, June 25 Catalyst: Discussion ...

Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals ... The median Dicerna employee made $311,375 last year. The biotech was able to grow its headcount by 63% last year, according to financial ...

(RTTNews) - Arrowhead Pharmaceuticals (ARWR), a clinical-stage biotech company, announced, on Tuesday, that it has entered into a global licensing and collaboration agreement with Sarepta ...

And while Wood said the pharma still isn’t interested in joining the overcrowded obesity landscape, GSK is considering ways ...

B. Riley upped their FY2025 earnings per share estimates for shares of Arrowhead Pharmaceuticals in a report issued on ...

Avoro Capital Advisors LLC increased its stake in Arrowhead Pharmaceuticals by 3.9% in the second quarter. Avoro Capital Advisors LLC now owns 8,888,888 shares of the biotechnology company’s ...

Sarepta Therapeutics’ Duchenne muscular dystrophy therapy Elevidys handily beat analysts’ expectations in the fourth quarter ...